Characterization of mAb dimers reveals predominant dimer forms common in therapeutic mAbs-Reference-Cited by-同舟云学术

Characterization of mAb dimers reveals predominant dimer forms common in therapeutic mAbs

Published:2016-03-31 Issue:5 Volume:8 Page:928-940
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Plath Friederike,Ringler Philippe,Graff-Meyer Alexandra,Stahlberg Henning,Lauer Matthias E.,Rufer Arne C.,Graewert Melissa A.,Svergun Dmitri,Gellermann Gerald,Finkler Christof,Stracke Jan O.,Koulov Atanas,Schnaible Volker

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/19420862.2016.1168960

Reference45 articles.

1. The therapeutic monoclonal antibody market

2. Development trends for human monoclonal antibody therapeutics

3. Forced Degradation of Therapeutic Proteins

4. Chemical Modifications in Therapeutic Protein Aggregates Generated under Different Stress Conditions

5. Shaken, Not Stirred: Mechanical Stress Testing of an IgG1 Antibody

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a scalable single process for producing SARS-CoV-2 RBD monomer and dimer vaccine antigens;Frontiers in Bioengineering and Biotechnology;2023-11-17

2. Optimization of Radiolabeling of a [90Y]Y-Anti-CD66-Antibody for Radioimmunotherapy before Allogeneic Hematopoietic Cell Transplantation;Cancers;2023-07-18

3. Development and biophysical characterization of a humanized FSH–blocking monoclonal antibody therapeutic formulated at an ultra-high concentration;eLife;2023-06-19

4. Development and Biophysical Characterization of a Humanized FSH–Blocking Monoclonal Antibody Therapeutic Formulated at an Ultra–High Concentration;2023-05-11

5. The Relationship between Protein–Protein Interactions and Liquid–Liquid Phase Separation for Monoclonal Antibodies;Molecular Pharmaceutics;2023-04-11